🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Clinical Trials in China / NCT07462546
Recruiting Not applicable

Transcranial Doppler for Internal Carotid Artery Stenting (TCD-ICAS)

NCT07462546 · tracked via the Priya Life Science China tracker
Sponsor
General Hospital of Shenyang Military Region
Phase
Not applicable
Started
2026-03-24
Last updated
2026-03-25

Condition(s) studied

Artery Stenosis

Investigational drug(s) / intervention(s)

Transcranial Doppler

Transcranial Doppler: TCD treatment (1.6 MHz, 0.274 MPa) from femoral artery puncture until 30-60 minutes after procedure completion

Study summary

Carotid artery stenting (CAS) prevents stroke but carries risks of perioperative cerebral embolism. Transcranial Doppler (TCD) ultrasound can detect microemboli during CAS and may offer therapeutic benefits through ultrasound-enhanced thrombolysis. Trials like SONOBUSTER and SONOBIRDIE suggest TCD reduces new brain infarctions during carotid procedures. The TCD-ICAS trial will investigate whether TCD application during and after CAS reduces perioperative cerebral emboli and improves outcomes.

Eligibility

Sex
ALL
Min age
40 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria: * Age ≥ 40 years old; * Patients with severe stenosis of the internal carotid artery; * Planned for carotid artery stent; * Modified Rankin Scale score ≤ 2; * The subject has adequate temporal bone windows to undergo TCD, and the blood flow signal of the middle cerebral artery is detectable.; * Signed informed consent by patient or their legally authorized representative. Exclusion Criteria: * Comorbid conditions with severe infections or severe diseases of the liver, kidney, hematopoietic system, endocrine system, etc.; * Occurrence of intracranial hemorrhage (cerebral parenchymal hemorrhage, subarachnoid hemorrhage, subdural/epidural hemorrhage) within 90 days prior to enrollment; * Severe hematological disorders or significant coagulation abnormalities; * Pregnant or breastfeeding women; * Participation in another clinical trial within the past 3 months or ongoing participation; * Any other circumstances deemed by the investigator as unsuitable for participation in this clinical study.

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Department of Neurology, General Hospital of Northern Theater Command Shenyang China Recruiting

More General Hospital of Shenyang Military Region trials in China

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07462546 on ClinicalTrials.gov ↗ ← All trials in China